The Jaguar Health (NASDAQ:JAGX) stock has rallied strongly this morning and has clocked gains of 15% already to take its gains for the past week to 30%.
The current optimism about the stock is related to the announcement of the findings by the company’s fully owned subsidiary company Napo Pharmaceuticals regarding outcomes in patients suffering from cancer-related diarrhea. The announcement was made last week.
In addition to that, it was also announced that the findings have also been accepted for a poster at the Annual Meeting of the American Society of Clinical Oncology (ASCO®). The event is going to be held between June 4 and June 8 this year. On the other hand, two other abstracts from Napo in relation to cancer-related diarrhea has been accepted by ASCO for online publication. Following the continued rally in the stock, investors could consider keeping an eye on any news in relation to Jaguar Health and Napo in the coming days.